Wilde Megan M, Schumacher Kurt R, Yu Sunkyung, Lowery Ray, Stoscup Jessica, Uzark Karen, Lim Heang M
Division of Pediatric Cardiology, Department of Pediatrics, Indiana University, Indianapolis, IN, USA.
Division of Pediatric Cardiology, Department of Pediatrics, Michigan Medicine, 1540 East Hospital Drive, Ann Arbor, MI, 48109-4204, USA.
Pediatr Cardiol. 2024 Oct 4. doi: 10.1007/s00246-024-03661-z.
Frailty is a clinical syndrome common in adults with chronic disease with resultant vulnerability to adverse health outcomes. Little is known about frailty in pediatric patients, including those with single-ventricle heart disease. This study aimed to examine the prevalence of frailty and its associated risk factors in patients with Fontan circulation. A single-center, prospective cohort study assessed frailty in patients (10-21 years old) after Fontan palliation. Slowness, weakness, exhaustion, shrinkage, and diminished physical activity were evaluated and scored using a modified Fried frailty assessment comprised of validated pediatric tests. Providers estimated subjects' degree of frailty. Patient-reported quality of life (QOL) was assessed. Of 54 participants (median age 15.3 years, 61% male), 18 (33%) were identified as frail, while 26 (48%) were pre-frail. Patients frequently exhibited frailty in the domains of slowness (93%), weakness (41%), and diminished physical activity (39%). There was poor correlation between frailty scores and provider estimates of frailty (Kappa = 0.11). Frail subjects had lower PedsQL physical functioning scores (mean 62.8 ± SD 18.5 in Frail vs. 75.7 ± 16.0 in No/pre-Frail; p = 0.01). Factors associated with frailty included protein-losing enteropathy (p = 0.03) and at least one hospitalization in the last year (p = 0.047). One-third of pediatric patients after Fontan palliation were frail which was associated with lower physical functioning and higher healthcare utilization. Providers poorly recognized frailty. These findings highlight the need for improved screening and support for an at-risk population where frailty is not easily identified.
衰弱是一种常见于患有慢性疾病的成年人中的临床综合征,会导致易出现不良健康后果。对于儿科患者,包括患有单心室心脏病的患者,人们对衰弱了解甚少。本研究旨在调查接受Fontan循环手术患者的衰弱患病率及其相关危险因素。一项单中心前瞻性队列研究评估了Fontan姑息治疗后患者(10至21岁)的衰弱情况。使用经过验证的儿科测试组成的改良Fried衰弱评估方法,对行动迟缓、虚弱、疲惫、体型缩小和身体活动减少进行评估和评分。医护人员估计受试者的衰弱程度。评估患者报告的生活质量(QOL)。在54名参与者(中位年龄15.3岁,61%为男性)中,18名(33%)被确定为衰弱,26名(48%)为衰弱前期。患者在行动迟缓(93%)、虚弱(41%)和身体活动减少(39%)方面经常表现出衰弱。衰弱评分与医护人员对衰弱的估计之间相关性较差(Kappa = 0.11)。衰弱受试者的儿童生活质量量表身体功能评分较低(衰弱组平均62.8±标准差18.5,非/衰弱前期组为75.7±标准差16.0;p = = 0.01)。与衰弱相关的因素包括蛋白丢失性肠病(p = = 0.03)和过去一年至少住院一次(p = = 0.047)。Fontan姑息治疗后的儿科患者中有三分之一衰弱,这与身体功能较低和更高的医疗利用率相关。医护人员对衰弱的识别能力较差。这些发现凸显了对难以识别衰弱的高危人群进行改进筛查和提供支持的必要性。